Autolus Therapeutics (AUTL) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free AUTL Stock Alerts $4.16 -0.23 (-5.24%) (As of 12:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Autolus Therapeutics Short Interest DataCurrent Short Interest3,520,000 sharesPrevious Short Interest4,070,000 sharesChange Vs. Previous Month-13.51%Dollar Volume Sold Short$12.95 millionShort Interest Ratio1.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares265,930,000 sharesPercentage of Shares Shorted1.32%Today's Trading Volume653,515 sharesAverage Trading Volume1,680,025 sharesToday's Volume Vs. Average39% Short Selling Autolus Therapeutics ? Sign up to receive the latest short interest report for Autolus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAUTL Short Interest Over TimeAUTL Days to Cover Over TimeAUTL Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Autolus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,520,000 shares $12.95 million -13.5%N/A1.9 $3.68 4/15/20244,070,000 shares $19.94 million -2.4%N/A2.6 $4.90 3/31/20244,170,000 shares $26.60 million +32.4%N/A2.6 $6.38 3/15/20243,150,000 shares $18.33 million +13.7%N/A1.9 $5.82 2/29/20242,770,000 shares $16.62 million -10.7%N/A1.7 $6.00 2/15/20243,100,000 shares $21.95 million +5.4%N/A1.9 $7.08 Get the Latest News and Ratings for AUTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,940,000 shares $17.70 million +21.5%N/A2.1 $6.02 1/15/20242,420,000 shares $17.40 million +12.0%N/A2.1 $7.19 12/31/20232,160,000 shares $13.91 million -18.5%N/A2.2 $6.44 12/15/20232,650,000 shares $13.28 million +26.8%N/A3.2 $5.01 11/30/20232,090,000 shares $8.95 million +41.2%N/A3.3 $4.28 11/15/20231,480,000 shares $6.28 million +0.7%N/A2.8 $4.24 10/31/20231,470,000 shares $4.15 million -2.0%N/A3.7 $2.82 10/15/20231,500,000 shares $3.53 million +5.6%N/A4.2 $2.35 9/30/20231,420,000 shares $3.31 million -11.8%N/A3.8 $2.33 9/15/20231,610,000 shares $4.62 million +17.5%N/A3.6 $2.87 8/31/20231,370,000 shares $4.40 million -16.5%N/A3 $3.21 8/15/20231,640,000 shares $4.51 million -12.3%N/A2.7 $2.75 7/31/20231,870,000 shares $6.04 million +18.4%N/A2.6 $3.23 7/15/20231,580,000 shares $3.89 million +6.0%N/A2.2 $2.46 6/30/20231,490,000 shares $3.55 million +4.9%N/A2.2 $2.38 6/15/20231,420,000 shares $4.02 million -11.8%N/A2.1 $2.83 5/31/20231,610,000 shares $5.01 million +117.7%N/A2.3 $3.11 5/15/2023739,700 shares $1.86 million -14.1%N/A1.3 $2.52 4/30/2023861,000 shares $1.56 million -33.3%N/A1.6 $1.81 4/15/20231,290,000 shares $2.32 million -24.1%N/A2.5 $1.80 3/31/20231,700,000 shares $3.13 million +40.5%N/A3.1 $1.84 3/15/20231,210,000 shares $2.53 million +7.1%N/A2.2 $2.09 2/28/20231,130,000 shares $2.19 million -10.3%N/A1.5 $1.94 2/15/20231,260,000 shares $2.42 million +43.6%N/A1.7 $1.92 1/31/2023877,400 shares $1.89 million +75.3%N/A1.3 $2.15 1/15/2023500,400 shares $1.05 million -24.3%N/A0.9 $2.10 12/30/2022661,000 shares $1.26 million +42.4%N/A1.2 $1.90 12/15/2022464,200 shares $858,770.00 -45.8%N/A1 $1.85 11/30/2022856,700 shares $2.26 million -19.2%N/A4.7 $2.64 11/15/20221,060,000 shares $2.12 million +16.9%N/A6.7 $2.00 10/31/2022906,900 shares $2.58 million -9.3%N/A5.8 $2.85 10/15/20221,000,000 shares $3.25 million -3.9%N/A6.4 $3.25 9/30/20221,040,000 shares $2.23 million -3.7%N/A7.7 $2.14 9/15/20221,080,000 shares $2.98 million -4.4%N/A8.4 $2.76The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. 8/31/20221,130,000 shares $3.73 million -3.4%N/A8.1 $3.30 8/15/20221,170,000 shares $4.40 million -10.7%N/A8 $3.76 7/31/20221,310,000 shares $3.65 million -7.8%N/A7.8 $2.79 7/15/20221,420,000 shares $4.08 million -11.8%N/A8 $2.87 6/30/20221,610,000 shares $4.56 million -5.3%N/A7.7 $2.83 6/15/20221,700,000 shares $3.47 million -16.3%N/A7.8 $2.04 5/31/20222,030,000 shares $5.56 million -1.5%N/A8.7 $2.74 5/15/20222,060,000 shares $4.88 million -4.2%N/A7.4 $2.37 4/30/20222,150,000 shares $6.71 million -0.5%N/A7.1 $3.12 4/15/20222,160,000 shares $8.73 million -13.9%N/A6.2 $4.04 3/31/20222,510,000 shares $10.47 million -13.8%4.0%6.8 $4.17 3/15/20222,910,000 shares $11.38 million -5.2%4.6%6.7 $3.91 2/28/20223,070,000 shares $11.48 million -0.3%6.1%5.9 $3.74 2/15/20223,080,000 shares $14.01 million +2.3%6.1%5.8 $4.55 1/31/20223,010,000 shares $12.01 million +10.7%N/A2.4 $3.99 1/15/20222,720,000 shares $12.00 million -0.7%N/A2.2 $4.41 12/31/20212,740,000 shares $14.22 million +18.1%N/A2.3 $5.19 12/15/20212,320,000 shares $13.08 million +12.6%N/A2 $5.64 11/30/20212,060,000 shares $13.25 million -17.6%N/A1.9 $6.43 11/15/20212,500,000 shares $16.98 million +39.7%N/A2.3 $6.79 10/29/20211,790,000 shares $9.99 million +3.5%N/A1.6 $5.58 10/15/20211,730,000 shares $10.62 million -12.2%N/A2.1 $6.14 9/30/20211,970,000 shares $12.90 million +4.2%N/A2 $6.55 9/15/20211,890,000 shares $12.47 million -21.6%N/A1.6 $6.60 8/31/20212,410,000 shares $16.56 million -14.2%N/A1.5 $6.87 8/13/20212,810,000 shares $16.61 million +30.1%N/A1.6 $5.91 7/30/20212,160,000 shares $11.49 million +10.2%N/A1 $5.32 7/15/20211,960,000 shares $11.52 million -2.0%N/A1.1 $5.88 6/30/20212,000,000 shares $13.28 million -11.9%N/A1.2 $6.64 6/15/20212,270,000 shares $17.32 million +1.8%N/A1.5 $7.63 5/28/20212,230,000 shares $14.78 million -3.9%N/A2 $6.63 5/14/20212,320,000 shares $14.04 million +57.8%N/A2.2 $6.05 4/30/20211,470,000 shares $8.38 million +14.8%N/A1.6 $5.70 4/15/20211,280,000 shares $7.17 million -66.7%N/A1.6 $5.60 3/31/20213,840,000 shares $21.08 million +3.8%N/A4.7 $5.49 3/15/20213,700,000 shares $24.79 million +5.4%N/A4.8 $6.70 2/26/20213,510,000 shares $22.96 million +105.3%N/A5.1 $6.54 2/12/20211,710,000 shares $12.21 million +130.0%N/A3 $7.14 1/29/2021743,600 shares $5.68 million +5.4%N/A3.7 $7.64 1/15/2021705,300 shares $6.30 million -0.1%N/A4 $8.93 12/31/2020705,900 shares $6.34 million -18.1%N/A4.6 $8.98 12/15/2020861,500 shares $7.32 million +8.2%N/A8.2 $8.50 11/30/2020796,000 shares $7.65 million +5.2%N/A9.7 $9.61 11/15/2020756,400 shares $8.30 million -2.3%N/A10.4 $10.97 10/30/2020774,200 shares $8.84 million +12.9%N/A9.6 $11.42 10/15/2020686,000 shares $8.39 million -5.9%N/A6.2 $12.23 9/30/2020729,300 shares $8.49 million +13.5%N/A4.9 $11.64 9/15/2020642,500 shares $8.87 million -15.9%N/A3.9 $13.81 8/31/2020763,900 shares $11.21 million +4.8%N/A3.7 $14.67 8/14/2020728,800 shares $11.66 million +12.1%N/A3.3 $16.00The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. 7/31/2020650,200 shares $8.58 million +24.1%N/A3 $13.20 7/15/2020523,800 shares $7.90 million +0.3%N/A2.7 $15.08 6/30/2020522,200 shares $8.37 million -38.6%N/A3 $16.03 6/15/2020850,100 shares $10.98 million +24.2%N/A4.8 $12.92 5/29/2020684,700 shares $7.76 million -13.7%N/A4.6 $11.33 5/15/2020793,500 shares $8.14 million +20.6%N/A5.5 $10.26 4/30/2020657,900 shares $6.20 million -3.6%N/A4.4 $9.42 4/15/2020682,300 shares $5.68 million +15.1%N/A3.4 $8.32 3/31/2020593,000 shares $6.07 million -5.9%N/A3.1 $10.24 3/13/2020630,400 shares $5.04 million -25.3%N/A3.7 $7.99 2/28/2020844,300 shares $3.74 million +6.0%N/A4.4 $4.43 2/14/2020796,800 shares $5.77 million -38.2%1.8%4.4 $7.24 1/31/20201,290,000 shares $11.98 million +26.5%2.9%7.5 $9.29 1/15/20201,020,000 shares $10.40 million -1.0%2.3%6.6 $10.20 12/31/20191,030,000 shares $10.05 million -3.7%2.3%9.2 $9.76 AUTL Short Interest - Frequently Asked Questions What is Autolus Therapeutics' current short interest? Short interest is the volume of Autolus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,520,000 shares of AUTL short. Learn More on Autolus Therapeutics' current short interest. What is a good short interest ratio for Autolus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AUTL shares currently have a short interest ratio of 2.0. Learn More on Autolus Therapeutics's short interest ratio. Which institutional investors are shorting Autolus Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Autolus Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Autolus Therapeutics' short interest increasing or decreasing? Autolus Therapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 3,520,000 shares, a drop of 13.5% from the previous total of 4,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Autolus Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Autolus Therapeutics: BioCryst Pharmaceuticals, Inc. (16.30%), Scholar Rock Holding Co. (16.78%), Cullinan Oncology, Inc. (10.23%), Immatics (10.50%), ProKidney Corp. (22.89%), Relay Therapeutics, Inc. (8.69%), Mesoblast Limited (0.79%), 4D Molecular Therapeutics, Inc. (18.61%), REGENXBIO Inc. (8.65%), CARGO Therapeutics, Inc. (13.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Autolus Therapeutics stock? Short selling AUTL is an investing strategy that aims to generate trading profit from Autolus Therapeutics as its price is falling. AUTL shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Autolus Therapeutics? A short squeeze for Autolus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AUTL, which in turn drives the price of the stock up even further. How often is Autolus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUTL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BioCryst Pharmaceuticals Short Squeeze Scholar Rock Short Squeeze Cullinan Oncology Short Squeeze Immatics Short Squeeze ProKidney Short Squeeze Relay Therapeutics Short Squeeze Mesoblast Short Squeeze 4D Molecular Therapeutics Short Squeeze REGENXBIO Short Squeeze CARGO Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AUTL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts